As muscle atrophy, NMJ degeneration, and α-MN death are pathological features of ALS [30], we hypothesized that NRIP could ameliorate these defects and enhance motor performance in ALS model mice. Here, DCAF6 is linked to amyotrophic lateral sclerosis.